Navigation Links
Codexis R&D Productivity Panels Also Used By Roche
Date:5/12/2009

REDWOOD CITY, Calif., May 12 /PRNewswire/ -- Codexis, Inc. today announced an agreement with Roche under which Roche will purchase Codex(TM) Biocatalyst Panels, a biocatalysis-based research and manufacturing productivity product.

The Codex(TM) Panels are used by pharmaceutical manufacturers to increase manufacturing productivity while reducing cost. They are based on Codexis proprietary custom biocatalysts, which can accelerate production of human therapeutics through early development of faster, lower cost, cleaner manufacturing processes. They have been used by more than 10 pharmaceutical companies worldwide.

"We are very pleased that Roche, a world leading company, will use Codexis biocatalysis technology to enhance pharmaceutical process manufacturing productivity," said Peter Seufer-Wasserthal, Ph.D., Senior Vice President, Codexis Pharmaceuticals. "Since their introduction in 2007, the Codex(TM) panels have been used to generate first kilogram quantities of a target material in weeks, instead of months. Some processes have already advanced to commercial scale. Shorter development time can contribute to lower drug development costs over many years - a priority in tight economic times."

Biocatalysts enable development of environmentally-friendly, low cost methods to produce chirally pure chemicals and have already replaced chemocatalysts in certain processes. Codexis offers panels covering major classes of enzymes that can produce a broad range of chemicals widely used by the pharmaceutical industry.

Sets of diagnostic enzyme panels are provided in a convenient 96-well format to efficiently determine if a biocatalytic solution is available for a challenging process step in the production of active pharmaceutical ingredients and intermediates needed to produce human therapeutics. Panel data is then used to rapidly develop product-specific, customized biocatalysts and biocatalyti
'/>"/>

SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Codexis Names Lori Giver VP Systems Biology
2. Codexis, Teva in Licensing Agreement Final
3. Codexis Names Vice President, Intellectual Property
4. Codexis, Arch Announce Expanded Collaboration
5. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
6. Codexis Names David Anton VP Bioindustrials R&D
7. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
8. Rothwell, Wolf Elected to Codexis Board
9. Codexis Opens Singapore Laboratory
10. Bruce Pasternack Elected to Codexis Board
11. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 Dendreon Corporation (Nasdaq: DNDN ... public offering of 15,000,000 shares of its common stock ... share. Dendreon also granted to the underwriters a ... shares of common stock to cover overallotments, if any. ... 15, 2009, subject to customary closing conditions. ,, J. ...
(Date:12/10/2009)... a division of the National Institutes of Health (NIH), awarded ... its development of a non-invasive, passive diffusion-based treatment for severe, ... ... Salt Lake City, UT (PRWEB) December 10, 2009 -- The ... of Health (NIH), awarded a $2.18 million grant to Aciont ...
(Date:12/10/2009)... YM BioSciences Inc. (NYSE Amex: YMI ; ... that identifies and advances a diverse portfolio of ... today provided an update on the proposed transaction ... Ltd. into YM, details of which were announced ... of Cytopia has unanimously recommended that its shareholders ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... FORD, Pa., Jan. 28 Endo Pharmaceuticals Inc. (Nasdaq: ... and 2008 full-year financial results on February 27, 2009 ... at 10:30 a.m. ET that day to discuss these ... Officer, Nancy J. Wysenski, Chief Operating Officer and Blaine ...
... Today the Swiss,pharmaceutical group Helsinn announced the ... with headquarters in,Bridgewater, New Jersey, for an undisclosed ... of a US-based R&D and commercial operation represents,attainment ... goals. "We are,thrilled at this very important opportunity ...
... NOVATO, Calif., Jan. 28 BioMarin Pharmaceutical,Inc. (Nasdaq: ... BioMarin, will host a conference call and webcast on,Wednesday, February ... quarter,and full year 2008 financial results. , , ... International Dial-in Number: 617.213.8835, Participant ...
Other Biology Technology:Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 3BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET) 2
(Date:12/14/2009)... researchers from the Astrobiology Centre (INTA-CSIC) has shown that ... the formation of the most basic biological molecules can ... to carry out this study, published in the journal ... chemical conditions of the early Earth. , "We have ... solutions it produces hydrogen cyanide, a substance that could ...
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
(Date:12/13/2009)... variants that are associated with the health of the ... 96 scientists from 63 centres in Europe and Australia ... diseases. , The new findings provide hope for better ... (COPD) and asthma. In the past it has been ... that affect the health of the lung are not ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 1iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 2iCRco Releases Clarity PACS a New Approach to Managing Digital Imaging Data 54156 3
... A rat thought extinct for 11 million years and a ... discovered in the Greater Mekong Region of Southeast Asia in ... World Wildlife Fund (WWF). , First Contact in ... newly identified by science between 1997 and 2007 which ...
... 15, 2008) A newly published genome sequence of ... rearranged genetic blueprint involving breaks and fusions of genes ... Baylor College of Medicine in a report that appears ... "It,s like a computer program that has become buggy ...
... study uncovers 11 gene variants associated with three ... low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) and ... nutrigenomics researchers looking for links between diet and ... disease risk. , "Practically all genes related to ...
Other Biology News:Over 1,000 species discovered in the Greater Mekong in past decade 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3New gene variants present opportunities in nutrigenomics 2
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
Complexin-1/2 (FL-134)...
RAW; Collected from 8-12 week old sexually mature mice that are free of common parasites; RAW Collected from 8-12 week old sexually mature mice that are free of common parasites....
Biology Products: